TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck.

Jennifer L Leddon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.